Thanks for making that clear Pharma.
CDY is retaining the intellectual property in order to monetise them at some later date (hopefully before the effectiveness of the patents runs out), whilst Lyramid is simply an R&D company (thereby relieving CDY of the R&D expenses).
So, for its ongoing capital, will CDY be providing that - or will Lyramid do its own CR's until it starts generating its own revenue?
I wonder how they will value Lyramid once it has been cut loose? It will either be a wondrous opportunity for initial investors ... or more of the same for existing shareholders.
- Forums
- ASX - By Stock
- Is this it?
Thanks for making that clear Pharma.CDY is retaining the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $336 | 42K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1457234 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 340000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1457234 | 0.008 |
2 | 1111500 | 0.007 |
4 | 1006527 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 340000 | 1 |
0.011 | 100000 | 1 |
0.012 | 100000 | 1 |
0.013 | 750000 | 1 |
0.015 | 440000 | 3 |
Last trade - 14.19pm 12/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |